Skip to main content

. 1983 Jul 2;287(6384):21–22. doi: 10.1136/bmj.287.6384.21-a

Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis.

B Lewis, W D Mitchell, C B Marenah, C Cortese, E H Reynolds, R Shakir

PMCID: PMC1548166 PMID: 6407679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Javitt N. B., Kok E., Cohen B., Burstein S. Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol. J Lipid Res. 1982 May;23(4):627–630. [PubMed] [Google Scholar]
Oftebro H., Björkhem I., Skrede S., Schreiner A., Pederson J. I. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. J Clin Invest. 1980 Jun;65(6):1418–1430. doi: 10.1172/JCI109806. [DOI] [PMC free article] [PubMed] [Google Scholar]
Stahl W. L., Sumi S. M., Swanson P. D. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis. J Neurochem. 1971 Mar;18(3):403–413. doi: 10.1111/j.1471-4159.1971.tb11968.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES